Urinary uroplakin expression in cyclophosphamide-induced rat cystitis model

被引:4
作者
Park, H. [1 ]
Kyung, Y. S. [2 ]
Lee, G. [1 ]
机构
[1] Dankook Univ, Dept Urol, Coll Med, San 29, Cheonan 330714, Chungnam, South Korea
[2] Univ Ulsan, Dept Hlth Screening & Promot Ctr, Asan Med Ctr, Coll Med, Seoul, South Korea
关键词
Cyclophosphamide; cystitis; uroplakin; hematuria; urine; SEVERE HEMORRHAGIC CYSTITIS; HEMATOPOIETIC-CELL TRANSPLANTATION; BLADDER; DIFFERENTIATION; CYSTECTOMY; ACROLEIN;
D O I
10.1177/0960327115597466
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
Cyclophosphamide (CYP) induces urothelial injury and causes excretion of cellular exudates at 24 h, followed by rapid restoration at 72 h. We investigated the role of urinary uroplakin II (UPII) levels in a CYP-induced cystitis model. For the purpose of this study, 10 controls and 26 CYP-injected female Sprague Dawley rats were killed at 24 h and 72 h postinjection. The vesical weight, severity of hematuria, and expression of UPII in the urinary bladder and urine were measured. CYP decreased the level of vesical UPII messenger RNA at 24 h, followed by rapid recovery at 72 h. Contrary to the negligible levels of urinary UPII and hematuria in controls, CYP treatment abruptly increased the excretion of urinary UPII at 24 h. The excretion had subsided at 72 h. Similarly, severe hematuria was observed at 24 h, with improvement at 72 h. However, some rats still exhibited hematuria at 72 h. CYP caused increase in vesical weight. The vesical weight at 24 h after CYP injection was negatively correlated with the vesical UPII level. Rats with significant hematuria demonstrated higher urinary UPII levels than those with insignificant hematuria. Vesical UPII could be an important barrier for early CYP-related injury, while the levels of urinary UPII may be associated with the severity of hematuria during dynamic periods in the urothelium.
引用
收藏
页码:613 / 622
页数:10
相关论文
共 21 条
  • [1] Urinary excretion and pharmacokinetics of acrolein and its parent drug cyclophosphamide in bone marrow transplant patients
    Al-Rawithi, S
    El-Yazigi, A
    Emst, P
    Al-Fiar, F
    Nicholls, PJ
    [J]. BONE MARROW TRANSPLANTATION, 1998, 22 (05) : 485 - 490
  • [2] Expressions of Uroplakins in the Mouse Urinary Bladder with Cyclophosphamide-Induced Cystitis
    Choi, Seong Hoo
    Byun, Youngmin
    Lee, Gilho
    [J]. JOURNAL OF KOREAN MEDICAL SCIENCE, 2009, 24 (04) : 684 - 689
  • [3] Epinephrine promotes hemostasis in rats with cyclophosphamide-induced hemorrhagic cystitis
    Chow, YC
    Yang, S
    Huang, CJ
    Tzen, CY
    Huang, PL
    Su, YH
    Wang, PS
    [J]. UROLOGY, 2006, 67 (03) : 636 - 641
  • [4] Role of CXCR2 and TRPV1 in functional, inflammatory and behavioural changes in the rat model of cyclophosphamide-induced haemorrhagic cystitis
    Dornelles, Fabiana N.
    Andrade, Edineia L.
    Campos, Maria M.
    Calixto, Joao B.
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2014, 171 (02) : 452 - 467
  • [5] Importance of Suitable Reference Gene Selection for Quantitative Real-Time PCR: Special Reference to Mouse Myocardial Infarction Studies
    Everaert, Bert R.
    Boulet, Gaelle A.
    Timmermans, Jean-Pierre
    Vrints, Christiaan J.
    [J]. PLOS ONE, 2011, 6 (08):
  • [6] FUKUSHIMA S, 1981, LAB INVEST, V44, P89
  • [7] Cystectomy for severe hemorrhagic cystitis in allogeneic stem cell transplant recipients
    Garderet, L
    Bittencourt, H
    Sebe, P
    Kaliski, A
    Claisse, JP
    Espérou, H
    Ribaud, P
    Estrade, V
    Gluckman, E
    Gattegno, B
    [J]. TRANSPLANTATION, 2000, 70 (12) : 1807 - 1811
  • [8] Successful treatment of severe hemorrhagic cystitis after hemopoietic cell transplantation by selective embolization of the vesical arteries
    Giné, E
    Rovira, M
    Real, I
    Burrel, M
    Montaña, J
    Carreras, E
    Montserrat, E
    [J]. BONE MARROW TRANSPLANTATION, 2003, 31 (10) : 923 - 925
  • [9] Economic evaluation of rituximab plus cyclophosphamide, vincristine and prednisolone for advanced follicular lymphoma
    Hornberger, John
    Reyes, Carolina
    Lubeck, Deborah
    Valente, Nancy
    [J]. LEUKEMIA & LYMPHOMA, 2008, 49 (02) : 227 - 236
  • [10] Careful Selection of Reference Genes Is Required for Reliable Performance of RT-qPCR in Human Normal and Cancer Cell Lines
    Jacob, Francis
    Guertler, Rea
    Naim, Stephanie
    Nixdorf, Sheri
    Fedier, Andre
    Hacker, Neville F.
    Heinzelmann-Schwarz, Viola
    [J]. PLOS ONE, 2013, 8 (03):